• Ionomycin Calcium Salt: Precision Tools for Decoding Ca2+ Si

  2026-07-01

  Explore Ionomycin calcium salt as a cutting-edge calcium ionophore for dissecting calcium signaling in cancer metastasis. This article provides a deep dive into mechanistic and assay design insights, highlighting recent advances and practical applications.

• Sulfaphenazole Restores Perfusion and Mitigates Pressure Inj

  2026-06-30

  This study demonstrates that Sulfaphenazole, a potent CYP2C9 inhibitor, rapidly restores tissue perfusion and reduces the severity of thermal and pressure injuries in a mouse model. The findings clarify the mechanistic role of CYP2C-mediated oxidative stress in ischemia-reperfusion injury and suggest translational value for vascular and wound healing research.

• Comparing Biomimetic Chromatography for Lung Drug Permeabili

  2026-06-30

  This study provides a direct comparison between immobilised artificial membrane liquid chromatography (IAM LC) and liposome electrokinetic capillary chromatography (LEKC) for evaluating drug partitioning and predicting pulmonary permeability. The findings clarify each method’s strengths and inform researchers modeling airway and asthma-related drug absorption.

• Faropenem Sodium: Transport Dynamics and Protocol Precision

  2026-06-29

  Explore Faropenem sodium as a penem antibiotic with unique renal transport dynamics and exceptional assay reproducibility. Uncover its distinct molecular pathway, advanced applications, and evidence-backed protocol insights for both Gram-positive and Gram-negative bacterial inhibition.

• HDAC3-Mediated TPM3 De-2-Hydroxyisobutyrylation Drives Vasoc

  2026-06-29

  This study uncovers how histone deacetylase 3 (HDAC3) regulates vasoconstriction by removing 2-hydroxyisobutyrylation (Khib) from tropomyosin 3 (TPM3) at lysine 141. The findings provide new insight into epigenetic regulation of vascular smooth muscle contractility and suggest a potential therapeutic target for hypertensive vascular dysfunction.

• 7-Ethyl-10-hydroxycamptothecin: Precision Tool for Colon Can

  2026-06-28

  7-Ethyl-10-hydroxycamptothecin (SN-38) stands out as a dual-action DNA topoisomerase I inhibitor and apoptosis inducer, offering robust, reproducible results in metastatic colon cancer models. This guide details experimental workflows, troubleshooting strategies, and the latest mechanistic insights—including FUBP1 pathway modulation—for advanced oncology research.

• Cy3-UTP: Advanced RNA Labeling for High-Precision Imaging

  2026-06-27

  Cy3-UTP empowers researchers to achieve single-nucleotide resolution in RNA imaging and interaction studies, thanks to its superior brightness and photostability. Seamless integration into in vitro transcription workflows makes it a go-to choice for probing complex RNA dynamics and function.

• Oscillatory mTORC1 Activity Orchestrates Cell Cycle and Auto

  2026-06-26

  Joshi et al. reveal that mTORC1 activity is not static but oscillates across the cell cycle, peaking in S/G2 phases and dropping in mitosis/G1. This dynamic regulation is crucial for mitotic entry and modulates autophagy sensitivity, offering a mechanistic link between metabolic state and cell division.

• Cinoxacin in Gram-Negative UTI Research: Protocols & Insight

  2026-06-26

  Cinoxacin stands out as a precision quinolone antibiotic for Gram-negative urinary tract infection and resistance research, offering rapid, reproducible DNA inhibition in bench workflows. This guide details stepwise protocols, troubleshooting strategies, and translational applications that leverage APExBIO's Cinoxacin for high-impact experimental design.

• Protein A/G Magnetic Beads: Protocol, QC, and Troubleshootin

  2026-06-25

  Protein A/G Magnetic Beads enable robust antibody purification and protein interaction analysis from complex samples by leveraging covalently linked recombinant Protein A and G domains. This product addresses challenges in immunoprecipitation, co-IP, and Ch-IP workflows, particularly where minimized non-specific binding is critical. Not suitable for diagnostic or medical purposes, these beads are designed for research use only.

• Erastin as a Ferroptosis Inducer: Protocols and Best Practic

  2026-06-25

  Erastin is a benchmark ferroptosis inducer, enabling precision modeling of iron-dependent cell death in RAS/BRAF-mutant tumor research. This guide translates the latest mechanistic insights and reference study findings into practical workflows, troubleshooting strategies, and comparative advantages for oxidative stress and cancer biology assays.

• Precision Nanoparticle Delivery of Doxycycline for AAA Thera

  2026-06-24

  This study presents a multifunctional nanoparticle system for delivering doxycycline directly to abdominal aortic aneurysm (AAA) lesions, addressing the longstanding challenge of targeted drug therapy in this vascular disease. The approach leverages bioactive tea polyphenol nanoparticles for controlled release and synergistic antioxidant, anti-inflammatory, and matrix metalloproteinase inhibitory effects.

• Metronidazole: Precision OAT3 Inhibition and Microbial Targe

  2026-06-23

  Metronidazole (2-(2-methyl-5-nitroimidazol-1-yl)ethanol) stands out for researchers seeking dual-action capabilities: potent OAT3 inhibition and targeted anaerobic bacteria control. This guide details actionable workflows, protocol optimization, and troubleshooting strategies leveraging APExBIO's high-purity Metronidazole for advanced drug-transporter and microbiota studies.

• Phase 2 Evidence: Gepotidacin’s Efficacy in Urogenital Gonor

  2026-06-23

  This phase 2 study demonstrates that single oral doses of gepotidacin (GSK2140944) achieve ≥95% microbiological cure rates in adults with uncomplicated urogenital gonorrhea, including infections by antibiotic-resistant Neisseria gonorrhoeae strains. The findings support gepotidacin’s potential as a new treatment option amid rising drug resistance, with well-characterized safety and protocol parameters.

• Dimetridazole-Cefotaxime Synergy Disrupts MDR E. coli Membra

  2026-06-22

  Wei et al. demonstrate that dimetridazole, a 1,2-dimethyl-5-nitroimidazole compound, significantly potentiates cefotaxime against multidrug-resistant E. coli by disrupting bacterial membrane integrity and altering fatty acid composition. These findings highlight an actionable strategy for reviving cephalosporin efficacy in antimicrobial resistance research.

447 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page